BECN1 had negative risk scores in two CRISPR screen datasets (Pan2018 OTI and PAN2018 Pmell), while OPTN had a negative risk score in M2 tumor-associated macrophages (Figure 8c). This evidence concerns the gene OPTN and neoplasm.